E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis

Cell Communication and Adhesion

Volumn 18, Issue 6, 2011, Pages 133-143

  Buda, Andrea ^a   Pignatelli, Massimo ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

adhesion molecules; APC; colorectal cancer; Cytoskeleton; E cadherin; Fascin

Indexed keywords

ADAM10 ENDOPEPTIDASE; APC PROTEIN; AXIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; BETA CATENIN; BEVACIZUMAB; CETUXIMAB; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOSKELETON PROTEIN; ENZASTAURIN; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MICRORNA 21; PLAKOGLOBIN; PROTEIN P120; STROMELYSIN; TRANSCRIPTION FACTOR SNAIL; TUMOR MARKER; UVOMORULIN; VITAMIN D; ZINC FINGER PROTEIN;

ADENOMATOUS POLYP; ADVANCED CANCER; ARTICLE; BINDING AFFINITY; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME 16Q; COLORECTAL CANCER; COLORECTAL CARCINOMA; DOWN REGULATION; ENTERITIS; ENZYME ACTIVITY; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HETEROZYGOSITY LOSS; HUMAN; IN VITRO STUDY; LIVER METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MICROSATELLITE INSTABILITY; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TUMOR GROWTH; TUMOR VOLUME; UBIQUITINATION; UPREGULATION; WNT SIGNALING PATHWAY;

ACTIN CYTOSKELETON; ADENOMATOUS POLYPOSIS COLI PROTEIN; CADHERINS; CARRIER PROTEINS; CATENINS; CELL ADHESION; CELL MOVEMENT; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SILENCER ELEMENTS, TRANSCRIPTIONAL; WNT SIGNALING PATHWAY;

EID: 84855433363     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419061.2011.636465     Document Type: Article

References (137)

1. Andarawewa KL, Erickson AC, Chou WS, et al. (2007). Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res. 67: 8662-8670. (Pubitemid 47439813)
2. Augustine CK, Yoshimoto Y, Gupta M, Zipfel PA, Selim MA, Febbo P, Pendergast AM, Peters WP, Tyler DS (2008). Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res. 68(10): 3777-3784.
3. Batlle E, Sancho E, Francí C, Domí nguez D, Monfar M, Baulida J, Garcí a De Herreros A (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2(2): 84-89.
4. Becker KF, Atkinson MJ, Reich U, Huang HH, Nekarda H, Siewert JR, Höfl er H (1993). Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet. 2(6): 803-804. (Pubitemid 23197530)
5. Behrens J (2000). Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci. 910: 21 - 33; discussion 33-35.
6. Benjamin JM, Kwiatkowski AV, Yang C, Korobova F, Pokutta S, Svitkina T, Weis WI, Nelson WJ (2010). AlphaE-catenin regulates actin dynamics independently of cadherin-mediated cell-cell adhesion. J Cell Biol. 189(2): 339-352.
7. Béroud C, Soussi T (1996). APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 24(1): 121-124. (Pubitemid 26085747)
8. Buda A, Pignatelli M (2004). Cytoskeletal network in colon cancer: from genes to clinical application. Int J Biochem Cell Biol. 36(5): 759-765. (Pubitemid 38299390)
9. Cai J, Ikeguchi M, Tsujitani S, Maeta M, Liu J, Kaibara N (2001). Signifi cant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Gastric Cancer. 4(2): 66-74. (Pubitemid 32903935)
10. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2(2): 76-83.
11. Carothers AM, Melstrom KA Jr, Mueller JD, Weyant MJ, Bertagnolli M (2001). Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice. J Biol Chem. 276(42): 39094-102.
12. Chan C, Jankova L, Fung CL, Clarke C, Robertson G, Chapuis PH, Bokey L, Lin BP, Dent OF, Clarke S (2010). Fascin expression predicts survival after potentially curative resection of nodepositive colon cancer. Am J Surg Pathol. 34(5): 656-666.
13. Chang KH, Miller N, Kheirelseid EA, Ingoldsby H, Hennessy E, Curran CE, Curran S, Smith MJ, Regan M, McAnena OJ, Kerin MJ (2011). MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol. 37(7): 597-603.
14. Chao YL, Shepard CR, Wells A (2010). Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer. 9: 179.
15. Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, Gao X, Guan HW, Li H (2005). Frequent loss of membranousE-cadherin in gastric cancers: a cross-talk with Wnt in determining the fate of beta-catenin. Clin Exp Metastasis. 22(1): 85-93. (Pubitemid 41185865)
16. Clevers H (2006). Wnt/beta-catenin signaling in development and disease. Cell .127: 469-80.
17. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F (2001). The two-handed E box binding zinc fi nger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 7(6): 1267-78. (Pubitemid 32607360)
18. Efstathiou JA, Liu D, Wheeler JM, Kim HC, Beck NE, Ilyas M, Karayiannakis AJ, Mortensen NJ, Kmiot W, Playford RJ, Pignatelli M, Bodmer WF ( 1999 ). Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci U S A. 96(5): 2316-2321. (Pubitemid 29117912)
19. Efstathiou JA, Pignatelli M (1998). Modulation of epithelial cell adhesion in gastrointestinal homeostasis. Am J Pathol. 153(2): 341-347. (Pubitemid 28373644)
20. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R (2005). DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 24(14): 2375-2385. (Pubitemid 40546696)
21. Fagotto F, Funayama N, Gluck U, Gumbiner BM (1996). Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus. J Cell Biol. 132(6): 1105-1114. (Pubitemid 26105498)
22. Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ, Layton MJ, Burgess AW (2004). Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J Cell Sci. 117 (Pt 3): 427-439. (Pubitemid 38181204)
23. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR (2008). MicroRNA expression profi les of esophageal cancer. J Thorac Cardiovasc Surg. 135(2): 255-260.
24. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W (1991). E-cadherin-mediated cellcell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 113(1): 173-185. (Pubitemid 21909684)
25. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, Sommer T, Birchmeier W (2002). Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 4(3): 222-231. (Pubitemid 34218196)
26. Gagliardi G, Kandemir O, Liu D, Guida M, Benvestito S, Ruers TG, Benjamin IS, Northover JM, Stamp GW, Talbot IC, et al. (1995). Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Arch. 426(2): 149-154.
27. Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, Karavitis G, Parassi I, Christeli E, Patrinos GP, Manolis EN, Peros G (2002). Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J Pathol. 198(4): 442-449. (Pubitemid 35446997)
28. Gold JS, Reynolds AB, Rimm DL (1998). Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival. Cancer Lett. 132(1 - 2): 193-201. (Pubitemid 28535205)
29. González-Sancho JM, Larriba MJ, Ordóñez-Morán P, Pálmer HG, Muñoz A ( 2006). Effects of 1alpha,25- dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res. 26(4A): 2669-2681. (Pubitemid 44155548)
30. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ (2008). The miR- 200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10(5): 593-601. (Pubitemid 351627379)
31. Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G, Adams JC (2006). Prognostic signifi cance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer. 6: 241.
32. Hayashi H, Nabeshima K, Aoki M, Hamasaki M, Enatsu S, Yamauchi Y, Yamashita Y, Iwasaki H (2010). Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion. Int J Cancer. 126(11): 2563-2574.
33. Hazan RB, Kang L, Whooley BP (1997). Borgen PIN-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun. 4(6): 399-411.
34. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000). Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 148(4): 779-790.
35. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998). Identifi cation of c-MYC as a target of the APC pathway. Science. 281: 1509-1512. (Pubitemid 28425575)
36. Hoshino H, Miyoshi N, Nagai K, Tomimaru Y, Nagano H, Sekimoto M, Doki Y, Mori M, Ishii H (2009). Epithelialmesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer. Biochem Biophys Res Commun. 390(3): 1061-1065.
37. Ireton RC, Davis MA, van Hengel J, Mariner DJ, Barnes K, Thoreson MA, Anastasiadis PZ, Matrisian L, Bundy LM, Sealy L, Gilbert B, van Roy F, Reynolds AB (2002). A novel role for p120 catenin in E-cadherin function. J Cell Biol Nov. 159(3): 465-476. (Pubitemid 35332833)
38. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M (2010). Epithelial-mesenchymal transition in cancer development and its clinical signifi cance. Cancer Sci. 101(2): 293-299.
39. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M, Adams JC (2003). Fascin, an actinbundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol. 162(1): 69-80. (Pubitemid 36041990)
40. Jiang W, Hiscox S (1997). beta-catenin-cell adhesion and beyond. Int J Oncol. 11(3): 635-641.
41. Jimbo T, Kawasaki Y, Koyama R, Sato R, Takada S, Haraguchi K, Akiyama T (2002). Identifi cation of a link between the tumour suppressor APC and the kinesin superfamily. Nat Cell Biol. 4(4): 323-327. (Pubitemid 34308860)
42. Johnson SK, Ramani VC, Hennings L, Haun RS Johnson SK (2007). Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer. 109(9): 1811-1820. (Pubitemid 46668545)
43. Kawasaki Y, Sato R, Akiyama T (2003). Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nat Cell Biol. 5(3): 211-215. (Pubitemid 36322247)
44. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, IwayamaY, Higuchi O, Akiyama T (2000). Asef, a link between the tumor suppressor APC and G-protein signaling. Science. 289(5482): 1194-1197. (Pubitemid 30650732)
45. Kinsella AR, Lepts GC, Hill CL, Jones M (1994). Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis. 12(4): 335-342. (Pubitemid 24257072)
46. Kinzler KW, Vogelstein B (1997). Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 386(6627): 761-763.
47. Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K, Flechtenmacher C, Angel P, Hess J (2007). Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 67(17): 8198-8206. (Pubitemid 47395156)
48. Korpal M, Lee ES, Hu G, Kang Y (2008). The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 283(22): 14910-14914.
49. Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC (2002). Fascins, and their roles in cell structure and function. Bioessays. 24(4): 350-361. (Pubitemid 34305690)
50. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R (2000). A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 60(4): 873-876. (Pubitemid 30129518)
51. Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY, Wang WJ, Chen Q, Tang F, Liu XP, Xu ZD (2011). Involvement of NF- B/miR-448 regulatory feedback loop in chemotherapyinduced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ. 18(1): 16-25.
52. Li T, Li D, Sha J, Sun P, Huang Y (2009). MicroRNA-21 directly argets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun. 383(3): 280-285.
53. Logan CY, Nusse R (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20: 781-810. (Pubitemid 39488658)
54. Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L, Jass JR (2007). Prognostic signifi cance of the wnt signaling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis. Histopathology. 50(4): 453-464. (Pubitemid 46328181)
55. Mahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A, Bertagnolli MM (1997). Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res. 57(22): 5045-5050. (Pubitemid 27498118)
56. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I (1993). E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res. 53(7): 1690-1695. (Pubitemid 23113253)
57. McCartney BM, Näthke IS (2008). Cell regulation by the Apc protein Apc as master regulator of epithelia. Curr Opin Cell Biol. 20(2): 186-193.
58. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 133(2): 647-658. (Pubitemid 47187346)
59. Mimori-Kiyosue Y, Shiina N, Tsukita S (2000). Adenomatous olyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells. J Cell Biol. 148(3): 505-518.
60. More H, Humar B, Weber W, Ward R, Christian A, Lintott C, Graziano F, Ruzzo AM, Acosta E, Boman B, Harlan M, Ferreira P, Seruca R, Suriano G, Guilford P ( 2007 ). Identifi cation of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat. 28(2): 203.
61. Nabeshima K, Shimao Y, Inoue T, Koono M (2002). Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. Cancer Lett. 176(1): 101-109. (Pubitemid 34085075)
62. Najy AJ, Day KC, Day ML (2008). The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J Biol Chem. 283(26): 18393-18401.
63. Nakamura T, Mitomi H, Kikuchi S, Ohtani Y, Sato K (2005). Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterol. 52(65): 1432-1435. (Pubitemid 41391008)
64. Nelson WJ (2009). Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity. Cold Spring Harb Perspect Biol. 1(1): a000513.
65. Noë V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M (2001). Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci. 114(Pt 1): 111-118. (Pubitemid 32120080)
66. Okada K, Bartolini F, Deaconescu AM, Moseley JB, Dogic Z, Grigorieff N, Gundersen GG, Goode BL (2010). Adenomatous polyposis coli protein nucleates actin assembly and synergizes with the formin mDia1. J Cell Biol. 189(7): 1087-1096.
67. Pálmer HG, Larriba MJ, Garcí a JM, Ordóñez- Morán P, Pe ña C, PeiróS, Puig I, Rodrí guez R, de la Fuente R, Bernad A, Pollán M, Bonilla F, Gamallo C, de Herreros AG, Mu ñoz A (2004). The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med. 10(9): 917-919. (Pubitemid 39273731)
68. Peinado H, Olmeda D, Cano A (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 7(6): 415-428. (Pubitemid 46809165)
69. Pe ña C, Garcí a JM, Larriba MJ, Barderas R, Gómez I, Herrera M, Garcí a V, Silva J, Domí nguez G, Rodrí guez R, Cuevas J, de Herreros AG, Casal JI, Mu ñoz A, Bonilla F (2009). SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene. 28(49): 4375-4385.
70. Pe ña C, Garcí a JM, Silva J, Garcí a V, Rodrí guez R, Alonso I, Millán I, Salas C, de Herreros AG, Mu ñoz A, Bonilla F (2005). E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet. 14(22): 3361-3370. (Pubitemid 41672120)
71. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 392(6672): 190-193. (Pubitemid 28162793)
72. Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli A, Carcangiu ML, Passera K, Braghetti A, Scaramuzza D, Zanaboni F, Fasolo A, Capri G, Miani M, Peters WP, Gianni L (2009). Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Ann Oncol. 20(4): 741-745.
73. Pino MS, Kikuchi H, Zeng M, Herraiz MT, Sperduti I, Berger D, Park DY, Iafrate AJ, Zukerberg LR, Chung DC (2010). Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterol. 138(4): 1406-1417.
74. Pittman AM, Twiss P, Broderick P, Lubbe S, Chandler I, Penegar S, Houlston RS (2009). The CDH1-160C> A polymorphism is a risk factor for colorectal cancer. Int J Cancer. 125(7): 1622-1625.
75. Puppa G, Maisonneuve P, Sonzogni A, Masullo M, Chiappa A, Valerio M, Zampino MG, Franceschetti I, Capelli P, Chilosi M, Menestrina F, Viale G, Pelosi G (2007). Independent prognostic value of fascin immunoreactivity in stage III - IV colonic adenocarcinoma. Br J Cancer. 96(7): 1118-1126. (Pubitemid 46608324)
76. Qualtrough D, Singh K, Banu N, Paraskeva C, Pignatelli M (2009). The actin-bundling protein fascin is overexpressed incolorectal adenomas and promotes motility in adenoma cells in vitro. Br J Cancer. 101(7): 1124-1129.
77. Raftopoulos I, Davaris P, Karatzas G, Karayannacos P, Kouraklis G (1998). Level of alpha-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survival. J Surg Oncol. 68(2): 92-99. (Pubitemid 28269976)
78. Ramí rez N, Bandrés E, Navarro A, Pons A, Jansa S, Moreno I, Martí nez-Rodenas F, Zárate R, Bitarte N, MonzóM, Garcí a- Foncillas J (2008). Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. Eur J Cancer. 44(17): 2689-2695.
79. Reilein A, Nelson WJ (2005). APC is a component of an organizing template for cortical microtubule networks. Nat Cell Biol. 7(5): 463-473. (Pubitemid 40637406)
80. Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z (1994). Identifi cation of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes, Mol Cell Biol. 14: 8333-8342.
81. Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA, McKeown C, Sanders DS, Maher ER ( 1999 ). Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 8(4): 607-610. (Pubitemid 29139974)
82. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS (1995). Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci U S A. 92(19): 8813-8817.
83. Rios-Doria J, Day KC, Kuefer R, Rashid MG, Chinnaiyan AM, Rubin MA, Day ML (2003). The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem. 278(2): 1372-1379. (Pubitemid 36790823)
84. Ropponen, K.M., Eskelinen MJ, Lipponen PK, Alhava EM, Kosma VM (1999). Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma. J Clin Pathol. 52(1): 10-16. (Pubitemid 29023501)
85. Sánchez-TillóE, Lázaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, Engel P, Postigo A (2010). ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene. 29(24): 3490-3500.
86. Sanz-Moreno V, Marshall CJ (2010). The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr Opin Cell Biol. 22(5): 690-696.
87. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008). MicroRNA expression profi les associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 299(4): 425-436. (Pubitemid 351185951)
88. Schmalhofer O, Brabletz S, Brabletz T ( 2009 ). E-cadherin, betacatenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 28(1 - 2): 151-166.
89. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN (2007). Altered MicroRNA expression confi ned to specifi c epithelial cell subpopulations in breast cancer. Cancer Res. 67(24): 11612-11620.
90. Serova M, Astorgues-Xerri L, Bieche I, Albert S, Vidaud M, Benhadji KA, Emami S, Vidaud D, Hammel P, Theou-Anton N, Gespach C, Faivre S, Raymond E (2010). Epithelial-tomesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cells. Mol Cancer Ther. 9(5): 1308-1317
91. Shao J, Mark Evers B, Sheng H (2004). Roles of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin/p70 Ribosomal Protein S6 Kinase in K-Ras- Mediated Transformation of Intestinal Epithelial Cells. Cancer Res. 64: 229-235. (Pubitemid 38114103)
92. Sharma M, Leung L, Brocardo M, Henderson J, Flegg C, Henderson BR (2006). Membrane localization of adenomatous polyposis coli protein at cellular protrusions: targeting sequences and regulation by beta-catenin. J Biol Chem. 281(25): 17140-17149.
93. Shen Y, Hirsch DS, Sasiela CA, Wu WJ (2008). Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway. J Biol Chem. 283(8): 5127-5137.
94. Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K, Kitamura N, Takeichi M, Ito F (1994). Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun. 1(4): 295-305.
95. Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T (2010). Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncol. 79(3 - 4): 313-320.
96. Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ, Johnson KR (2008). ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. Int J Cancer. 122(1): 71-77. (Pubitemid 350209980)
97. Shioiri M, Shida T, Koda K, Oda K, Seike K, Nishimura M, Takano S, Miyazaki M (2006). Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer. 94(12): 1816-1822. (Pubitemid 43882571)
98. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M (1996). E-cadherin mediated adhesion system in cancer cells. Cancer. 77(8 Suppl): 1605-1613. (Pubitemid 26111841)
99. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo HH (2007). MiR-21- mediated tumor growth, Oncogene. 26; pp. 2799 - 2803. (Pubitemid 46663837)
100. Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N, Settleman J (2009). A gene expression signature associated with ' K-Ras addiction ' reveals regulators of EMT and tumor cell survival. Cancer Cell. 15(6): 489-500.
101. Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, Jung A, Kirchner T, Brabletz T (2006). A transient, EMTlinked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterol. 131(3): 830-840. (Pubitemid 44307069)
102. St Croix B, Sheehan C, Rak JW, Fl Ø renes VA, Slingerland JM, Kerbel RS (1998). E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol. 142(2): 557-571. (Pubitemid 28361560)
103. Strathdee, G 2002. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol. 12(5): 373-379.
104. Strumane K, Berx G, Van Roy F (2004). Cadherins in cancer. Handb Exp Pharmacol. 165: 69-103.
105. Takeichi M (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 251(5000): 1451-1455. (Pubitemid 121000430)
106. Tanaka M, Hashiguchi Y, Ueno H, Hase K, Mochizuki H (2003). Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum. 46(8): 1054-1059. (Pubitemid 36992987)
107. Tetsu O, McCormick F (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398: 422-426. (Pubitemid 29180374)
108. Thiery JP, Acloque H, Huang RY, Nieto MA (2009). Epithelialmesenchymal transitions in development and disease. Cell. 139(5): 871-890.
109. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2(6): 442-454.
110. Trotter KW, Archer TK (2008) The BRG1 transcriptional coregulator. Nucl Recept Signal. 6.
111. Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S, Jin JS (2007). Overexpression of fascin-1 in advanced colorectal carcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers. 23: 153-160. (Pubitemid 46868405)
112. Tsukamoto H, Shibata K, Kajiyama H, Terauchi M, Nawa A, Kikkawa F (2007). Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol. 107(3): 500-504. (Pubitemid 350160864)
113. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002). Tumour ' budding ' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathol. 40(2): 127-132. (Pubitemid 34122114)
114. Valizadeh A, Karayiannakis AJ, el-Hariry I, Kmiot W, Pignatelli M (1997). Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. Am J Pathol. 150(6): 1977-1984. (Pubitemid 27233071)
115. van Roy F, Berx G (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 65(23): 3756-3788.
116. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F, Berx G (2004). IP1/ ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 33(20): 6566-6578. (Pubitemid 41806421)
117. Vécsey-Semjén B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA (2002). Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Oncogene. 21(30): 4646-4662. (Pubitemid 34833142)
118. Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, Hall NR, Jones M, Wyatt J, Miller K, Ward U, Al- Maskatti J, Singh SM, Finan PJ, Ambrose NS, Primrose JN, Selby PJ (1998). Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer. 77(11): 1857-1863. (Pubitemid 28254624)
119. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66(1): 107-119. (Pubitemid 121001351)
120. Volmer MW, Stühler K, Zapatka M, Schöneck A, Klein-Scory S, Schmiegel W, Meyer HE, Schwarte-Waldhoff (2005). Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics. 5(10): 2587-2601. (Pubitemid 40966486)
121. Wali RK, Kunte DP, Koetsier JL, Bissonnette M, Roy HK ( 2008 ). Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail. Mol Cancer Ther. 7(9): 3103-3111.
122. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT, Wong YC (2004). Identifi cation of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogen. 23: 474-482. (Pubitemid 38175002)
123. Watanabe T, Wang S, Noritake J, Sato K, Fukata M, Takefuji M, Nakagawa M, Izumi N, Akiyama T, Kaibuchi K (2004). Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin fi laments during cell polarization and migration. Dev Cell. 7(6): 871-883. (Pubitemid 39654731)
124. Weiß JV, Klein-Scory S, Kübler S, Reinacher-Schick A, Stricker I, Schmiegel W, Schwarte-Waldhoff I (2011). Soluble E-cadherin as a serum biomarker candidate: elevated levels in late stage colorectal carcinoma patients and in FAP. Int J Cancer. 128(6): 1384-1392.
125. Wells A, Yates C, Shepard CR (2008). E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis. 25(6): 621-628.
126. Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJ, Chen M, Wallar BJ, Alberts AS, Gundersen GG (2004). EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol. 6(9): 820-830. (Pubitemid 39207247)
127. Wheeler JM, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJ, Bodmer WF (2001). Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut. 48(3): 367-371. (Pubitemid 32269565)
128. Wijnhoven BP, Pignatelli M (1999). E-cadherin-catenin: more than a ' sticky ' molecular complex. Lancet. 354(9176): 356-357. (Pubitemid 29355748)
129. Williams E, Williams G, Gour BJ, Blaschuk OW, Doherty P (2000). A novel family of cyclic peptide antagonists suggests that N-cadherin specifi city is determined by amino acids that fl ank the HAV motif. J Biol Chem. 275(6): 4007-4012. (Pubitemid 30094629)
130. Wilmanns C, Grossmann J, Steinhauer S, Manthey G, Weinhold B, Schmitt-Gräff A, von Specht BU (2004). Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients. Clin Exp Metastasis. 21(1): 75-78. (Pubitemid 38365660)
131. Wong NA, Pignatelli M (2002). Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol. 160(2): 389-401.
132. Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K, Yu J, SJJ (2011). MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenes. 32(3): 247-253.
133. Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis L (2006). Mascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 66(1): 46-51. (Pubitemid 43166007)
134. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 117(7): 927-939. (Pubitemid 38798858)
135. Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, Wu KJ (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 10(3): 295-305.
136. Yates CC, Shepard CR, Stolz DB, Wells A (2007). Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer. 96(8): 1246-1252. (Pubitemid 46625074)
137. Yost C, Torres M, Miller JR, Huang E, Kimelman D, Moon RT (1996). The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10(12): 1443-1454. (Pubitemid 26260702)